Literature DB >> 10707877

The potential of gene therapy in the treatment of hepatocellular carcinoma.

C Qian1, M Drozdzik, W H Caselmann, J Prieto.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10707877     DOI： 10.1016/s0168-8278(00)80082-3

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  5 in total

Review 1.  Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignancies.

Authors:  V Schmitz; C Qian; J Ruiz; B Sangro; I Melero; G Mazzolini; I Narvaiza; J Prieto
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

2.  NT4(Si)-p53(N15)-antennapedia induces cell death in a human hepatocellular carcinoma cell line.

Authors:  Li-Ping Song; Yue-Ping Li; Ning Wang; Wei-Wei Li; Juan Ren; Shu-Dong Qiu; Quan-Ying Wang; Guang-Xiao Yang
Journal:  World J Gastroenterol       Date:  2009-12-14       Impact factor: 5.742

3.  14-kDa Phosphohistidine phosphatase plays an important role in hepatocellular carcinoma cell proliferation.

Authors:  Su-Xia Han; Li-Juan Wang; Jing Zhao; Ying Zhang; Meng Li; Xia Zhou; Jing Wang; Qing Zhu
Journal:  Oncol Lett       Date:  2012-07-13       Impact factor: 2.967

4.  Application of doxorubicin-induced rAAV2-p53 gene delivery in combined chemotherapy and gene therapy for hepatocellular carcinoma.

Authors:  Chun-Ann Chen; Cheng-Kai Lo; Bai-Ling Lin; Eric Sibley; Shiue-Cheng Tang
Journal:  Cancer Biol Ther       Date:  2007-11-21       Impact factor: 4.742

5.  Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth in vitro and in vivo.

Authors:  Xiaohua Li; Yanglin Pan; Rui Fan; Haifeng Jin; Shuang Han; Jie Liu; Kaichun Wu; Daiming Fan
Journal:  Carcinogenesis       Date:  2008-02-24       Impact factor: 4.944
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.